Related Experiment Video
Updated: Feb 21, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
IL-37 and 38 signalling in gestational diabetes
Zhiyan Yu1, Jun Liu2, Rui Zhang2
1Department of Endocrinology, Fifth People's Hospital, Fudan University, Shanghai 200240, China; Discipline of Pathology, Bosch Institute and School of Medical Sciences, University of Sydney, 2006, Australia.
Interleukin-37 (IL-37) reduction and Interleukin-38 (IL-38) increase in placenta and umbilical cord tissues are linked to gestational diabetes mellitus (GDM). These cytokine changes suggest an immune-mediated mechanism in GDM development.
Area of Science:
- Reproductive immunology
- Maternal-fetal medicine
- Inflammatory diseases
Background:
- Gestational diabetes mellitus (GDM) poses a global health challenge, with inflammation implicated in its pathogenesis.
- The specific roles of Interleukin-37 (IL-37) and Interleukin-38 (IL-38) in GDM development remain largely unexplored.
- Existing research highlights the involvement of IL-37 and IL-38 in autoimmune conditions, prompting investigation into their function in pregnancy.
Purpose of the Study:
- To investigate the expression levels of IL-37 and IL-38 in placental and umbilical cord tissues of women with GDM compared to non-GDM controls.
- To determine the correlation between IL-37 and IL-38 levels and the development of GDM.
- To elucidate the potential immune-mediated mechanisms underlying GDM pathogenesis involving these cytokines.
Main Methods:
- Histopathology and immunohistochemistry were employed to assess placental and umbilical cord tissue characteristics.
- Quantitative real-time PCR (qRT-PCR) was used to measure placental mRNA expression of IL-37 and IL-38.
- Enzyme-linked immunosorbent assay (ELISA) was utilized to evaluate serum levels of IL-37 and IL-38.
Main Results:
- IL-37 expression was significantly reduced in the chorionic villi, umbilical artery, and umbilical vein of GDM placentas compared to controls.
- Conversely, IL-38 expression was markedly increased in the chorionic villi, umbilical artery, and umbilical vein of GDM placentas.
- Reduced IL-37 and elevated IL-38 levels were also observed in the serum of women with GDM.
Conclusions:
- The findings suggest that decreased IL-37 may protect pregnant women against GDM development.
- Elevated IL-38 in placental and umbilical cord tissues may represent a localized inflammatory response during GDM progression.
- The observed dysregulation of IL-37 and IL-38 points towards an immune-mediated mechanism contributing to GDM pathogenesis, offering potential targets for intervention.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: The Receptor and Signaling Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...

